SRS Capital Advisors »

Allogene Therapeutics shares owned by SRS Capital Advisors

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by SRS Capital Advisors from 13F filings

Historical chart of SRS Capital Advisors investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by SRS Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by SRS Capital Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $92k 44k 2.08
2026-03-31 $2.0k 834 2.44
2025-09-30 $46k 37k 1.24

More positions owned by SRS Capital Advisors

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds Growth Etf (VUG)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Comfort Systems USA (FIX)
Microsoft Corporation (MSFT)
Vanguard Index Fds Total Stk Mkt (VTI)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Whitehall Fds High Div Yld (VYM)
Vanguard Index Fds Value Etf (VTV)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for SRS Capital Advisors

Top funds holding Allogene Therapeutics

BlackRock
Frazier Life Sciences Management
Pfizer
Tpg Gp A
Sio Capital Management
PRIMECAP Management Company
Vanguard Capital Management
FMR
Citadel Advisors
State Street Corporation
Two Sigma Investments
Geode Capital Management
Goldman Sachs Group
T. Rowe Price Associates
Marshall Wace

View all funds holding Allogene Therapeutics